-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Itopride is a medication used to treat gastrointestinal disorders such as irritable bowel syndrome, constipation, and gastroesophageal reflux disease (GERD).
It is also known as a prokinetic agent, which means it helps to strengthen the muscles of the digestive system and improve the movement of food through the gastrointestinal tract.
The synthesis of itopride involves several steps, which can be organized into three main synthetic routes: the PMB-Oxidation, the Mannich reaction and the Schuster reaction.
The PMB-Oxidation is a key step in the synthesis of itopride.
Para-Methoxybenzyl alcohol (PMB) is treated with sodium periodate in the presence of a base such as sodium hydroxide.
This leads to the formation of PMB-phenoxide, which is then treated with hydrogen peroxide to give PMB-benzyl alcohol.
The benzyl group is then deprotected using hydrochloric acid to give the phenolic hydroxyl group.
This intermediate can then be treated with various reagents such as benzylhalide, benzaldehyde, and 4-chloroacetophenone to give the corresponding benzylhalide or benzaldehyde derivative.
The Mannich reaction is another key step in the synthesis of itopride.
The phenolic hydroxyl group obtained from the PMB-oxidation is treated with carbon disulfide and a primary or secondary amine in the presence of a solvent such as benzene or toluene.
This leads to the formation of a Mannich base, which is then treated with a mineral acid such as hydrochloric acid or sulfuric acid to give the corresponding carboxylic acid.
This intermediate can then be treated with a variety of reagents such as chloroformates and bromoformates to give the corresponding chloride or bromide derivative.
The Schuster reaction is the final step in the synthesis of itopride.
The carboxylic acid obtained from the Mannich reaction is treated with a Grignard reagent such as phenylmagnesium bromide in the presence of a base such as sodium hydroxide.
This leads to the formation of a methyl ketone, which can then be treated with various reagents such as methyl iodide, methyl sulfate, and methyl nitrate to give the corresponding methyl ester derivative.
These three synthetic routes are widely used in the pharmaceutical industry for the synthesis of itopride, with the PMB-oxidation being the most commonly used method.
The synthesis of itopride requires the use of several reagents and solvents, and the reaction conditions must be carefully controlled to ensure the formation of a pure and stable intermediate.
The synthesis of itopride is an important step in the development of new drugs for the treatment of gastrointestinal disorders, and ongoing research is focused on improving the efficiency and selectivity of the synthetic routes.
In conclusion, itopride is a medication used to treat gastrointestinal disorders, and its synthesis involves the PMB-Oxidation, the Mannich reaction and the Schuster reaction.
These three synthetic routes are widely used in the pharmaceutical industry for the synthesis of itopride.
While the PMB-oxidation is the most commonly used method, the Mannich reaction and the Schuster reaction are also important steps in the synthesis of itopride.
The synthesis of itopride requires the use of several reagents and solvents, and the reaction conditions must be carefully controlled to ensure the formation of a pure and stable intermediate.
The development of new drugs for the treatment of gastrointestinal disorders is an ongoing process and the synthesis of itopride is an important step in this process.